QNCX

Quince Therapeutics
QNCX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$49.72M
EV
$23.75M
Shares Outstanding
44.09M
Beta
0.74

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$7.25
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Quince Therapeutics, Inc.

gainify
QNCX

Quince Therapeutics, Inc.

QNCX

Quince Therapeutics, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company’s lead asset candidature comprises EryDex for the treatment of rare pediatric neuro...

Sector

Healthcare

Industry

Biotechnology

CEO

Thye, Dirk

Employees

36

IPO Date

2019-05-09

Headquarters

611 Gateway Boulevard, Suite 273, South San Francisco, California, 94080, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved